BridgeMD
New treatment option for Respiratory Disorder
Official title Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
ClinicalTrials.gov ID: NCT05973201
What this study is testing
- What it's testing
- Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (over 18 years of age)
- Hospitalized in a critical care unit (intensive care and intensive care)
- Conscious (Glasgow score \>13)
- Spontaneous ventilation
- Requiring the realization of a FB
You likely can't join if
- Non-French-speaking patient
- Protected minors or adults who cannot consent to participate
- People with major neurocognitive impairment
- Patient refusing to participate in the study
- Patient on State medical aid
- Patient under guardianship or curatorship or under judicial protection
See the full eligibility criteria
- Adults (over 18 years of age)
- Hospitalized in a critical care unit (intensive care and intensive care)
- Conscious (Glasgow score \>13)
- Spontaneous ventilation
- Requiring the realization of a FB
- First BF during hospitalization
- Having signed a consent to participate in the study
- Affiliation to social security
- Non-French-speaking patient
- Protected minors or adults who cannot consent to participate
- People with major neurocognitive impairment
- Patient refusing to participate in the study
- Patient on State medical aid
- Patient under guardianship or curatorship or under judicial protection
- BF for a vital emergency
- Prior inclusion in the study
- Pregnant or breastfeeding women
- Presence of a tracheostomy or tracheostomy
- Participation in other intervention research
- Epilepsy
- Visual impairment (blindness) or severe hearing impairment (hearing loss, deafness) that does not allow the use of the helmet
- Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
- Autism spectrum disorders
- Patient sensitive to motion sickness
- Refractory migraine under treatment
The study team makes the final eligibility decision.
Where it's taking place
- Aix-en-Provence, France
- Dijon, France
- Le Kremlin-Bicêtre, France
- Paris, France
- Suresnes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aix-en-Provence, France; Dijon, France; Le Kremlin-Bicêtre, France; Paris, France; Suresnes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.